David Whiteman
PersonHeard in 3 episodes across 2 shows since Sep 2026
David Whiteman is an Australian medical epidemiologist associated with QIMR Berghofer Medical Research Institute. He researches cancer epidemiology, including the relationship between ultraviolet exposure, sunscreen use, and skin cancer.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 2 |
| Oct 2026 | 1 |
| Nov 2026 | 0 |
Email alert
Email me when David Whiteman comes up on a podcast
One email a week at most, with the new episodes that mention David Whiteman. Free, no account needed, unsubscribe in one click.
What David Whiteman has said on podcasts
20 statements
Calendar meetings can serve as an upstream indicator of a GP’s deal access.
“you could use this calendar and these meetings as this upstream indicator of a GP's access”
Open the episode · E453: Quantifying Venture Capital, Finding the Next Anthropic, and the Science of Picking WinnersListen at 31:34
Engineers may eventually replace salespeople, but the transition could take 10–20 years.
“It might take 10, 20 years.”
Open the episode · E452: Why 95% of AI Projects Fail, Anthropic’s Valuation, and Why AI Is Still in the First InningListen at 44:42
Venture capital’s portfolio role is delivering occasional outsized asymmetric returns.
“that is to deliver outsized asymmetric returns once in a while.”
Open the episode · E448: Gavin Ezekowitz on AI Valuations, Asymmetric Returns, and Why Great Investors FailListen at 29:59
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring David Whiteman, newest first
- Oct 23, 2026
AI turns software into a platform for digital workersHow I Invest with David WeisburdOct 23, 2026Guest - Sep 30, 2026
Venture investors turn instinct into evidenceHow I Invest with David WeisburdSep 30, 2026 - Sep 6, 2026
Sunscreen science exposes gaps in testing and researchUp First from NPRSep 6, 2026